Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | MOR | ACLX | MLTX | ||
Company | Morphosys Ag ADR | Arcellx Inc | Moonlake Immunotherapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 18.06 | 51.52 | 41.68 | ||
High | 18.15 | 51.97 | 42.65 | ||
Low | 18.02 | 49.66 | 41.20 | ||
Last | 18.11 | 51.38 | 42.25 | ||
Change | -0.02 | -1.44 | -0.18 | ||
% Change | -0.11% | -2.73% | -0.42% | ||
Volume | 116,500 | 631,700 | 264,800 | ||
20-Day Average Volume | 341,250 | 470,490 | 411,750 | ||
Previous Close | 18.05 | 52.82 | 42.43 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 18.06 | 58.47 | 44.90 | ||
20-Day Raw Stochastic | 78.79% | 8.06% | 12.83% | ||
20-Day Relative Strength | 65.29% | 34.20% | 38.34% | ||
Weighted Alpha | +80.85 | +0.71 | +3.70 | ||
Today's Opinion | 100% Buy | 8% Sell | 88% Sell | ||
Previous Opinion | 88% Buy | 8% Sell | 96% Sell | ||
Last Month's Opinion | 100% Buy | 100% Buy | 24% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.44% since 04/18/24 | -5.72% since 04/18/24 | unch since 04/18/24 | ||
Low | 17.90 on 04/22/24 | 49.66 on 04/25/24 | 40.68 on 04/19/24 | ||
High | 18.15 on 04/25/24 | 55.94 on 04/23/24 | 43.60 on 04/24/24 | ||
1-Month | |||||
%Chg | -0.11% since 03/25/24 | -25.35% since 03/25/24 | -18.34% since 03/25/24 | ||
Low | 17.87 on 04/03/24 | 49.66 on 04/25/24 | 40.68 on 04/19/24 | ||
High | 18.20 on 04/09/24 | 71.39 on 03/27/24 | 53.20 on 03/26/24 | ||
3-Month | |||||
%Chg | +83.69% since 01/25/24 | -13.41% since 01/25/24 | -25.50% since 01/25/24 | ||
Low | 10.02 on 01/26/24 | 49.66 on 04/25/24 | 40.68 on 04/19/24 | ||
High | 18.31 on 03/12/24 | 75.10 on 03/07/24 | 64.98 on 02/12/24 | ||
6-Month | |||||
%Chg | +153.57% since 10/25/23 | +58.73% since 10/25/23 | -17.56% since 10/25/23 | ||
Low | 4.18 on 11/22/23 | 30.88 on 10/27/23 | 35.11 on 11/06/23 | ||
High | 18.31 on 03/12/24 | 75.10 on 03/07/24 | 64.98 on 02/12/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,730,759 | 2,738,040 | 2,699,226 | ||
Shares Outstanding, K | 150,621 | 53,290 | 63,887 | ||
Annual Sales | 257,890,000 | 110,320,000 | 0 | ||
Annual Net Income | -205,350,000 | -70,690,000 | -36,010,000 | ||
Last Quarter Sales | 63,610,000 | 63,150,000 | 0 | ||
Last Quarter Net Income | 53,170,000 | 19,840,000 | -5,330,000 | ||
60-Month Beta | 1.17 | 0.02 | 1.20 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.33 on 03/13/24 | 0.42 on 02/28/24 | -0.12 on 02/29/24 | ||
Latest Earnings Date | 05/01/24 | 05/13/24 | 05/10/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |